EpiSign International: Expanding Epigenomic Testing in Rare Disease
EpiSign International: Expanding Epigenomic Testing in Rare Disease
Not yet recruiting · NCT07839754 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EpiSign International: Expanding Epigenomic Testing in Rare Disease | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, Undiagnosed Diseases, hereditary disease | Not yet recruiting | Not stated | 2026-09-24 | NCT07839754 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Manchester | 85 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Manchester Centre for Genomic Medicine, 6th Floor, St Mary's Hospital, Oxford Road | Manchester | United Kingdom | 1 |